ReviewCurrent oncology reports2019
Non-Melanoma Skin Cancers in the Older Patient.
Review in Current oncology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 40 citations in OpenAlex.
- A SHort course Accelerated RadiatiON therapy (SHARON) dose-escalation trial in older adults head and neck non-melanoma skin cancer.The British journal of radiology · 2022Trial
- Certainties, Doubts, and Myths in the Diagnosis and Treatment of Salivary Gland Tumors of the Head and Neck.Cancers · 2026Review
- Barriers to Skin Cancer Diagnosis and Treatment in Low- and Middle-Income Countries and Solutions: A Literature Review.Public health challenges · 2025Review
- Basal Cell Carcinoma in Patients over 80 Years Presenting for Surgical Excision: Clinical Characteristics and Surgical Outcomes.Current oncology (Toronto, Ont.) · 2025Observational
- Innovative approach to designing user-centred digital solutions for plastic surgery patients with non-melanoma skin cancer.Frontiers in public health · 2025Article
- Application Value of High Resolution Magnetic Resonance Imaging in Preoperative Evaluation of Non-melanoma Skin Cancer.Current medical imaging · 2025Article
- Global Burden of Non-Melanoma Skin Cancer Among Elder Adults and Projections to 2071: A Systematic and Comprehensive Analysis of the Global Burden of Disease Study 2021.Clinical, cosmetic and investigational dermatology · 2025Article
- Association ofCurrent issues in molecular biology · 2024Article
- Positive and negative feedback regulation of the TGF-β1 explains two equilibrium states in skin aging.iScience · 2024Article
- Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.Healthcare (Basel, Switzerland) · 2024Article
- Systemic immune-inflammation index values are associated with non-melanoma skin cancers: evidence from the National Health and Nutrition Examination Survey 2010-2018.Archives of medical science : AMS · 2024Article
- The levels and trends of cancer incidence in the elderly population at national and sub-national scales in Iran from 1990 to 2016.Cancer reports (Hoboken, N.J.) · 2024Article
- Article
- Advanced non-melanoma skin cancer in elderly patients: When surgery says NO, interventional radiotherapy (brachytherapy) says YES.Journal of contemporary brachytherapy · 2023Article
- A Multicenter Prospective Trial of Electronic Skin Surface Brachytherapy for Keratinocyte Carcinoma: Early Cosmesis, Quality of Life, and Adverse Events.International journal of radiation oncology, biology, physics · 2023Article
- An epidemiological study on skin tumors of the elderly in a community in Shanghai, China.Scientific reports · 2023Article
- Surgical Treatment of Nonmelanoma Skin Cancer in Older Adult Veterans.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2022Article
- Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland.Acta dermato-venereologica · 2022Article
- Skin cancers and their risk factors in older persons: a population-based study.BMC geriatrics · 2022Article
- High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - a single-centre experience.Contemporary oncology (Poznan, Poland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe incidence of non-melanomatous skin cancer (NMSC) increases with age and there are specific considerations regarding management of NMSC for the older patient population. Here we will review current data regarding treatment considerations and options for older patients with NMSC. RECENT
findingsHypofractionated regimens and high-dose brachytherapy may be non-surgical treatment options for older patients with NMSC. Other less aggressive strategies such as active surveillance can also be considered in some settings. Management of NMSC in the older patient population requires a thorough assessment of comorbidities, frailty, and life expectancy. Additionally, discussions regarding goals of care and quality of life (QOL) issues are especially important in this population. Older patients with NMSC in particular may benefit from a tailored treatment plan based on current available data rather than a broad application of general treatment guidelines for NMSC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.